Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Altered Plasmodium falciparum Sensitivity to the Antiretroviral Protease Inhibitor Lopinavir Associated with Polymorphisms in pfmdr1.

Sonoiki E, Nsanzabana C, Legac J, Sindhe KM, DeRisi J, Rosenthal PJ.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e01949-16. doi: 10.1128/AAC.01949-16. Print 2017 Jan.

PMID:
27821443
2.

An integrative analysis of small molecule transcriptional responses in the human malaria parasite Plasmodium falciparum.

Siwo GH, Smith RS, Tan A, Button-Simons KA, Checkley LA, Ferdig MT.

BMC Genomics. 2015 Dec 4;16:1030. doi: 10.1186/s12864-015-2165-1.

3.

Enzymatic Characterization of Recombinant Food Vacuole Plasmepsin 4 from the Rodent Malaria Parasite Plasmodium berghei.

Liu P, Robbins AH, Marzahn MR, McClung SH, Yowell CA, Stevens SM Jr, Dame JB, Dunn BM.

PLoS One. 2015 Oct 28;10(10):e0141758. doi: 10.1371/journal.pone.0141758. eCollection 2015.

4.

Pharmacokinetic interactions between artesunate-mefloquine and ritonavir-boosted lopinavir in healthy Thai adults.

Rattanapunya S, Cressey TR, Rueangweerayut R, Tawon Y, Kongjam P, Na-Bangchang K.

Malar J. 2015 Oct 9;14:400. doi: 10.1186/s12936-015-0916-8.

5.

Presence of Plasmodium falciparum DNA in Plasma Does Not Predict Clinical Malaria in an HIV-1 Infected Population.

Orlov M, Smeaton LM, Kumwenda J, Hosseinipour MC, Campbell TB, Schooley RT.

PLoS One. 2015 Jun 8;10(6):e0129519. doi: 10.1371/journal.pone.0129519. eCollection 2015.

6.

Neither the HIV protease inhibitor lopinavir-ritonavir nor the antimicrobial trimethoprim-sulfamethoxazole prevent malaria relapse in plasmodium cynomolgi-infected non-human primates.

Hobbs CV, Dixit S, Penzak SR, Sahu T, Orr-Gonzalez S, Lambert L, Zeleski K, Chen J, Neal J, Borkowsky W, Wu Y, Duffy PE.

PLoS One. 2014 Dec 26;9(12):e115506. doi: 10.1371/journal.pone.0115506. eCollection 2014.

7.

Isothermal microcalorimetry accurately detects bacteria, tumorous microtissues, and parasitic worms in a label-free well-plate assay.

Braissant O, Keiser J, Meister I, Bachmann A, Wirz D, Göpfert B, Bonkat G, Wadsö I.

Biotechnol J. 2015 Mar;10(3):460-8. doi: 10.1002/biot.201400494. Epub 2015 Feb 18.

8.

Lopinavir/ritonavir-based antiretroviral treatment (ART) versus efavirenz-based ART for the prevention of malaria among HIV-infected pregnant women.

Natureeba P, Ades V, Luwedde F, Mwesigwa J, Plenty A, Okong P, Charlebois ED, Clark TD, Nzarubara B, Havlir DV, Achan J, Kamya MR, Cohan D, Dorsey G.

J Infect Dis. 2014 Dec 15;210(12):1938-45. doi: 10.1093/infdis/jiu346. Epub 2014 Jun 23.

9.

Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system.

Lee J, Jo DG, Park D, Chung HY, Mattson MP.

Pharmacol Rev. 2014 Jul;66(3):815-68. doi: 10.1124/pr.113.007757. Review.

10.

The effect of antiretrovirals on Plasmodium falciparum liver stages.

Hobbs CV, De La Vega P, Penzak SR, Van Vliet J, Krzych U, Sinnis P, Borkowsky W, Duffy PE.

AIDS. 2013 Jun 19;27(10):1674-7. doi: 10.1097/QAD.0b013e3283621dd4.

11.

Transition-state inhibitors of purine salvage and other prospective enzyme targets in malaria.

Ducati RG, Namanja-Magliano HA, Schramm VL.

Future Med Chem. 2013 Jul;5(11):1341-60. doi: 10.4155/fmc.13.51. Review.

12.

Evaluation of Paracheck-Pf(TM) rapid malaria diagnostic test for the diagnosis of malaria among HIV-positive patients in Ibadan, south-western Nigeria.

Falade CO, Adesina-Adewole B, Dada-Adegbola HO, Ajayi IO, Akinyemi JO, Ademowo OG, Adewole IF, Kanki P.

Pathog Glob Health. 2013 Mar;107(2):69-77. doi: 10.1179/2047773213Y.0000000077.

13.

Prevalence of asymptomatic parasitemia and gametocytemia among HIV-infected Ugandan children randomized to receive different antiretroviral therapies.

Ikilezi G, Achan J, Kakuru A, Ruel T, Charlebois E, Clark TD, Rosenthal PJ, Havlir D, Kamya MR, Dorsey G.

Am J Trop Med Hyg. 2013 Apr;88(4):744-6. doi: 10.4269/ajtmh.12-0658. Epub 2013 Jan 28.

14.

Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children.

Achan J, Kakuru A, Ikilezi G, Ruel T, Clark TD, Nsanzabana C, Charlebois E, Aweeka F, Dorsey G, Rosenthal PJ, Havlir D, Kamya MR.

N Engl J Med. 2012 Nov 29;367(22):2110-8. doi: 10.1056/NEJMoa1200501.

15.

ATP and luciferase assays to determine the rate of drug action in in vitro cultures of Plasmodium falciparum.

Khan T, van Brummelen AC, Parkinson CJ, Hoppe HC.

Malar J. 2012 Nov 7;11:369. doi: 10.1186/1475-2875-11-369.

16.

Prevalence and clinical features of HIV and malaria co-infection in hospitalized adults in Beira, Mozambique.

Saracino A, Nacarapa EA, da Costa Massinga EA, Martinelli D, Scacchetti M, de Oliveira C, Antonich A, Galloni D, Ferro JJ, Macome CA.

Malar J. 2012 Jul 26;11:241. doi: 10.1186/1475-2875-11-241.

17.

The frequency of malaria is similar among women receiving either lopinavir/ritonavir or nevirapine-based antiretroviral treatment.

Skinner-Adams TS, Butterworth AS, Porter KA, D'Amico R, Sawe F, Shaffer D, Siika A, Hosseinipour MC, Stringer E, Currier JS, Chipato T, Salata R, Lockman S, Eron JJ, Meshnick SR, McCarthy JS.

PLoS One. 2012;7(4):e34399. doi: 10.1371/journal.pone.0034399. Epub 2012 Apr 3.

18.

Antimalarial activity of the anticancer histone deacetylase inhibitor SB939.

Sumanadasa SD, Goodman CD, Lucke AJ, Skinner-Adams T, Sahama I, Haque A, Do TA, McFadden GI, Fairlie DP, Andrews KT.

Antimicrob Agents Chemother. 2012 Jul;56(7):3849-56. doi: 10.1128/AAC.00030-12. Epub 2012 Apr 16.

19.

Saquinavir inhibits the malaria parasite's chloroquine resistance transporter.

Martin RE, Butterworth AS, Gardiner DL, Kirk K, McCarthy JS, Skinner-Adams TS.

Antimicrob Agents Chemother. 2012 May;56(5):2283-9. doi: 10.1128/AAC.00166-12. Epub 2012 Feb 21.

20.

HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study.

Porter KA, Cole SR, Eron JJ Jr, Zheng Y, Hughes MD, Lockman S, Poole C, Skinner-Adams TS, Hosseinipour M, Shaffer D, D'Amico R, Sawe FK, Siika A, Stringer E, Currier JS, Chipato T, Salata R, McCarthy JS, Meshnick SR.

Antimicrob Agents Chemother. 2012 Feb;56(2):995-1000. doi: 10.1128/AAC.05322-11. Epub 2011 Nov 28.

Supplemental Content

Support Center